Braidwell LP Buys 495,577 Shares of Acadia Healthcare Company, Inc. $ACHC

Braidwell LP boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 76.7% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,141,477 shares of the company’s stock after buying an additional 495,577 shares during the quarter. Braidwell LP’s holdings in Acadia Healthcare were worth $33,708,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Acadia Healthcare during the second quarter worth about $441,685,000. Goldman Sachs Group Inc. boosted its holdings in Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after acquiring an additional 3,815,471 shares during the last quarter. Jefferies Financial Group Inc. acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $106,458,000. Wellington Management Group LLP increased its position in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the period. Finally, Vaughan Nelson Investment Management L.P. bought a new position in Acadia Healthcare during the 1st quarter worth approximately $43,017,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Barclays upped their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. TD Cowen lifted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Guggenheim upped their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $27.75 on Thursday. The stock has a market capitalization of $2.58 billion, a price-to-earnings ratio of -2.23, a PEG ratio of 9.10 and a beta of 0.62. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock’s 50 day moving average price is $30.64 and its two-hundred day moving average price is $26.42.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same quarter in the previous year, the business posted $0.83 EPS. Acadia Healthcare’s revenue for the quarter was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.